Jim Simons Ab Cellera Biologics Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 3,360,729 shares of ABCL stock, worth $12.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,360,729

Previous 3,307,429 1.61%

Holding current value

$12.4 Million

Previous $11.3 Million 49.01%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.49 - $5.15 $186,017 - $274,495	53,300 Added 1.61%	3,360,729 $16.9 Million
Q2 2025 Aug 13, 2025	BUY	$1.93 - $3.8 $797,862 - $1.57 Million	413,400 Added 14.28%	3,307,429 $11.3 Million
Q1 2025 May 14, 2025	BUY	$2.2 - $3.53 $895,699 - $1.44 Million	407,136 Added 16.37%	2,894,029 $6.45 Million
Q4 2024 Feb 13, 2025	SELL	$2.48 - $3.15 $1.14 Million - $1.45 Million	-459,810 Reduced 15.6%	2,486,893 $7.29 Million
Q3 2024 Nov 13, 2024	BUY	$2.39 - $3.49 $2.91 Million - $4.25 Million	1,218,100 Added 70.47%	2,946,703 $7.63 Million

Q2 2024 Aug 09, 2024	BUY	$2.73 - $4.73 $652,470 - $1.13 Million	239,000 Added 16.04%	1,728,603 $5.12 Million
Q1 2024 May 13, 2024	BUY	$4.29 - $5.97 $129,129 - $179,697	30,100 Added 2.06%	1,489,603 $6.75 Million
Q4 2023 Feb 13, 2024	SELL	$3.91 - $5.93 $909,270 - $1.38 Million	-232,550 Reduced 13.74%	1,459,503 $8.33 Million
Q3 2023 Nov 14, 2023	SELL	$4.6 - $7.95 $3.88 Million - $6.71 Million	-844,550 Reduced 33.29%	1,692,053 $7.78 Million
Q2 2023 Aug 11, 2023	SELL	$5.66 - $7.59 $1.56 Million - $2.09 Million	-274,900 Reduced 9.78%	2,536,603 $16.4 Million
Q1 2023 May 12, 2023	BUY	$7.31 - $11.18 $5.04 Million - $7.7 Million	689,100 Added 32.47%	2,811,503 $21.2 Million
Q4 2022 Feb 13, 2023	SELL	$9.48 - $14.52 $8.14 Million - $12.5 Million	-858,400 Reduced 28.8%	2,122,403 $21.5 Million
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $9.71 Million - $14.4 Million	-1,055,500 Reduced 26.15%	2,980,803 $29.5 Million
Q2 2022 Aug 12, 2022	BUY	$5.72 - $10.65 $8.11 Million - $15.1 Million	1,418,700 Added 54.2%	4,036,303 $43 Million
Q1 2022 May 13, 2022	BUY	$7.46 - $14.14 $15.5 Million - $29.4 Million	2,078,400 Added 385.46%	2,617,603 $25.5 Million
Q4 2021 Feb 11, 2022	BUY	$12.99 - $17.73 $5.91 Million - $8.07 Million	454,903 Added 539.62%	539,203 $7.71 Million
Q3 2021 Nov 12, 2021	SELL	$14.85 - $21.34 $4.74 Million - $6.81 Million	-318,900 Reduced 79.09%	84,300 $1.69 Million
Q2 2021 Aug 13, 2021	BUY	$20.19 - $34.17 $8.14 Million - $13.8 Million	403,200 New	403,200 $8.87 Million

Others Institutions Holding ABCL

# of Institutions

169

Shares Held

109M

Call Options Held

1.26M

Put Options Held

788K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.05B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account